BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34477243)

  • 21. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
    Alatan H; Chen Y; Zhou J; Wang L
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer.
    Han J; Zhang X; Liu Y; Jing L; Liu YB; Feng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32797167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of MicroRNA-Target Gene-Transcription Factor Regulatory Networks in Colorectal Adenoma Using Microarray Expression Data.
    Gao Y; Zhang S; Zhang Y; Qian J
    Front Genet; 2020; 11():463. PubMed ID: 32508878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
    Chen C; Wu Y; Lu HL; Liu K; Qin X
    PeerJ; 2022; 10():e13138. PubMed ID: 35313524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma.
    Gao HX; Wang MB; Li SJ; Niu J; Xue J; Li J; Li XX
    Curr Med Sci; 2020 Oct; 40(5):885-899. PubMed ID: 32980897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
    Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
    BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
    Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.
    Hashemi Gheinani A; Burkhard FC; Rehrauer H; Aquino Fournier C; Monastyrskaya K
    J Biol Chem; 2015 Mar; 290(11):7067-86. PubMed ID: 25596533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of hub genes and pathways in colorectal cancer with microarray technology.
    Wang Y; Zheng T
    Pathol Oncol Res; 2014 Jul; 20(3):611-8. PubMed ID: 24504536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.
    Harada T; Yamamoto E; Yamano HO; Nojima M; Maruyama R; Kumegawa K; Ashida M; Yoshikawa K; Kimura T; Harada E; Takagi R; Tanaka Y; Aoki H; Nishizono M; Nakaoka M; Tsuyada A; Niinuma T; Kai M; Shimoda K; Shinomura Y; Sugai T; Imai K; Suzuki H
    Cancer Prev Res (Phila); 2014 Oct; 7(10):1002-10. PubMed ID: 25139296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of hub genes and pathways in lung metastatic colorectal cancer.
    Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
    BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
    Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer.
    Katoh M
    Int J Oncol; 2001 Nov; 19(5):1003-7. PubMed ID: 11605001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.